What is neuromedicine-assisted psychotherapy?
Neuromedicine-assisted psychotherapy (NMAP) refers to the use of psychoactive medicines (including those sometimes referred to as ‘psychedelics’) together with psychological therapy.
NMAPs are emerging as a potent tool to alleviate those mental health disorders, including depression, PTSD, OCD, anxiety and addiction, that don’t respond to conventional treatments.
Better Minds will explore the use of a range of neuromedicines and therapies to find ways of improving outcomes.
Generally, there are three stages:
Traditional approaches to mental illnesses usually entail a tablet being taken each day for months or years, or attending therapy sessions for extended periods.
One of the most striking differences with neuromedicine-assisted psychotherapy is the duration of therapeutic effects achieved with short-term treatment. Just two or three sessions can produce positive results lasting longer than six months.